Contents of this document
- Operating profit for the fiscal year ended March 20251 Millions of yen
- Global DI-24 Millions of yen
- Entertainment-9 Millions of yen
- IT-related76 Millions of yen
- Wellness-30 Millions of yen
- Other SG&A expenses and related items-29 Millions of yen
- Operating loss for the fiscal year ended March 2026-15 Millions of yen
- Established the Wellness business
- Acquired domestic sales rights for MyWaves Technologies products
- Sales of sleep-tech products through Sun Digital Health
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | 9,907 Millions of yen (YoY -8.5%) |
| Operating profit | -15 Millions of yen |
| Ordinary income | 5,133 Millions of yen (YoY +623.1%) |
| Net income | 9,663 Millions of yen (YoY -43.9%) |
| Gross Profit Margin | Rate 27.9% (full year) / Year-on-year change (points) Up 1.7 percentage points from 26.2% in the previous full year |
| Operating profit margin | Rate Not calculated or presented for the full year (0.0%) / Year-on-year change (points) Deteriorated from 0.0% in the previous full year |
| Selling, general and administrative expenses | 2,778 Millions of yen |
| Results for the three months of the current quarter | Net Sales 2,505 Millions of yen / Operating profit 121 Millions of yen / Ordinary income 1,633 Millions of yen / Net income 2,767 Millions of yen |
| Full-year earnings forecast | Net Sales 19,222 Millions of yen / Operating profit 2,131 Millions of yen / Ordinary income 8,300 Millions of yen / Profit attributable to owners of the parent 7,600 Millions of yen |
| Segment results | Global Data Intelligence business Net Sales 1,293 Millions of yen (YoY +8.2%) / Segment profit 140 Millions of yen (YoY -14.6%) / Entertainment-related business Net Sales 5,477 Millions of yen (YoY -6.6%) / Segment profit 648 Millions of yen (YoY -1.4%) / IT-Related Business Net Sales 3,158 Millions of yen (YoY -16.9%) / Segment profit 332 Millions of yen (YoY +29.8%) / Wellness Net Sales Not disclosed / Segment profit -30 Millions of yen |
| Breakdown of Factors Affecting the Change | Factors Operating profit for the fiscal year ended March 2025 / Amount 1 Millions of yen, Factors Global DI / Amount -24 Millions of yen, Factors Entertainment / Amount -9 Millions of yen, Factors IT-related / Amount 76 Millions of yen, Factors Wellness / Amount -30 Millions of yen, Factors Other SG&A expenses and related items / Amount -29 Millions of yen, Factors Operating loss for the fiscal year ended March 2026 / Amount -15 Millions of yen |
| Annual Dividend | Annual dividend per share ¥50 / Interim and Year-End Breakdown Year-end: ¥50 |
| New initiatives | Established the Wellness business, Acquired domestic sales rights for MyWaves Technologies products, Sales of sleep-tech products through Sun Digital Health |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The decline in revenue was attributable to lower shipment volumes of gaming machine components and other products in the entertainment-related business, as well as the completion of demand for the migration from 3G to LTE and delays in the development and market launch of 5G and edge AI-related products in the IT-related business. The increase in ordinary income was attributable to the recognition of ¥4,969 million in equity-method investment income from Cellebrite. The decline in net income was due to a ¥12,832 million year-on-year decrease in the gain on changes in Cellebrite's equity interest.